HSD17B10 and prostate carcinoma: Furthermore, there is emergingevidence showing that increases in 17β-HSD10 activity have animportant role in various hormone-dependent cancers, including breastand bone cancers, but especially castrate-resistant prostate cancer,which has a very poor outcome and no cure (reviewed in Vinklarovaet al.).